宇笛生物科技股份有限公司
- 主成分
- Clindamycin Hydrochloride has a potency equivalent to not less than 758 μg of clindamycin per mg, calculated on the anhydrous.
- 適應症
- 抗生素。
- 主成分
- Acetaminophen 98.0-102.0% (on the dried basis)
- 適應症
- 鎮痛藥，解熱藥。
- 主成分
- Clindamycin Hydrochloride contains NLT 800 μg/ mg of C18H33CIN2O5S, calculated on dried basis.
- 適應症
- 抗生素。
- 主成分
- It contains the equivalent of not less than 76.5 percent of Al(OH)3.
- 適應症
- 制酸劑
- 主成分
- Sulfasalazine contains not less than 97.0% and not more than 101.5% of C18H14N4O5S, calculated on the dried substance.
- 適應症
- 抗炎劑(胃腸系統)。
- 主成分
- Iron Sucrose Complex Solution ([Na2Fe5O8(oH)3H2O]n‧m(C12H22O11)]) Assay for Iron (by UV) Not less than 3.4% w/w. Assay for sucrose by HPLC (2.0% W/V of Iron solution) Not less than 260 mg and not more than 340 mg of sucrose per ml.
- 適應症
- 補血劑。
- 主成分
- Oxolamine Citrate contains not less than 99.0% and not more than 101.0% of C20H27N3O8 calculated on dried substance.
- 適應症
- 鎮咳劑。
- 主成分
- Bosentan monohydrate contains NLT 98.0% w/w and NMT 102.0% w/w of Bosentan monohydrate [C27H29N5O6S.H2O], calculated on anhydrous basis.
- 適應症
- 抗高血壓劑
- 主成分
- Iron (III) Hydroxide Polymaltose Complex [(Fe(OH)3(H2O)15)]n．[(C6H10O5)m]x Assay Polymaltose content (on Anhydrous basis): between 25.0 and 50.0%. ww Iron content (on as basis): between 25.0 and 40.0% ww
- 適應症
- 鐵質不足及鐵質不足引起之貧血症
- 主成分
- Mebeverine Hydrochloride contains not less than 99.0% and not more than 101.0% of C25H36ClNO5, calculated on the dried substance.
- 適應症
- 平滑肌鬆弛劑